Loperamide hydrochloride
- CAS No.
- 34552-83-5
- Chemical Name:
- Loperamide hydrochloride
- Synonyms
- LOPERAMIDE HCL;suprasec;imodium;4-(4-(p-chlorophenyl)-4-hydroxy-1-piperidyl)-n,n-dimethyl-2,2-diphenylbutyra;4-(4-CHLOROPHENYL)-4-HYDROXY-N,N-DIMETHYL-ALPHA,ALPHA-DIPHENYL-1-PIPERIDINBUTYRAMIDE HYDROCHLORIDE;4-(4-CHLOROPHENYL)-4-HYDROXY-N,N-DIMETHYL-ALPHA,ALPHA-DIPHENYL-1-PIPERIDINEBUTANAMIDE HYDROCHLORIDE;blox;pj185;imosec;Imosse
- CBNumber:
- CB8758181
- Molecular Formula:
- C29H34Cl2N2O2
- Molecular Weight:
- 513.5
- MDL Number:
- MFCD00058581
- MOL File:
- 34552-83-5.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Melting point | 223-225°C |
|---|---|
| Density | 1.1905 (rough estimate) |
| refractive index | 1.6100 (estimate) |
| storage temp. | 2-8°C |
| solubility | Slightly soluble in water, freely soluble in ethanol (96 per cent) and in methanol. |
| pka | 8.66(at 25℃) |
| form | Solid |
| color | White to Almost white |
| Merck | 14,5571 |
| Major Application |
forensics and toxicology pharmaceutical (small molecule) |
| InChI | InChI=1S/C29H33ClN2O2.ClH/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H |
| InChIKey | PGYPOBZJRVSMDS-UHFFFAOYSA-N |
| SMILES | C(C(=O)N(C)C)(CCN1CCC(O)(C2C=CC(Cl)=CC=2)CC1)(C1=CC=CC=C1)C1=CC=CC=C1.Cl |
| CAS DataBase Reference | 34552-83-5(CAS DataBase Reference) |
| NCI Dictionary of Cancer Terms | Imodium; loperamide hydrochloride |
| FDA UNII | 77TI35393C |
| NCI Drug Dictionary | Imodium A-D |
| UNSPSC Code | 41116107 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS06 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H301 | |||||||||
| Precautionary statements | P301+P330+P331+P310 | |||||||||
| PPE | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges | |||||||||
| Hazard Codes | T | |||||||||
| Risk Statements | 25 | |||||||||
| Safety Statements | 45 | |||||||||
| RIDADR | UN 2811 6.1/PG 3 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | TM4960000 | |||||||||
| HazardClass | 6.1(b) | |||||||||
| PackingGroup | III | |||||||||
| HS Code | 29333990 | |||||||||
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
|||||||||
| Hazard Classifications | Acute Tox. 3 Oral | |||||||||
| Toxicity | LD50 in mice (mg/kg): 75 s.c.; 28 i.p.; 105 orally; in rats (mg/kg): 185 orally (Niemegeers) | |||||||||
| NFPA 704 |
|
Loperamide hydrochloride price More Price(57)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | L0750000 | Loperamide hydrochloride European Pharmacopoeia (EP) Reference Standard | 34552-83-5 | 50 mg | $175 | 2026-04-30 | Buy |
| Sigma-Aldrich | BP635 | Loperamide hydrochloride British Pharmacopoeia (BP) Reference Standard | 34552-83-5 | 100MG | $263 | 2026-04-30 | Buy |
| Sigma-Aldrich | 5.08162 | Loperamide Hydrochloride - CAS 34552-83-5 - Calbiochem | 34552-83-5 | 1g | $169 | 2026-04-30 | Buy |
| Sigma-Aldrich | 34014 | Loperamide hydrochloride VETRANAL?, analytical standard | 34552-83-5 | 100mg | $61.3 | 2026-04-30 | Buy |
| Sigma-Aldrich | 1370000 | Loperamide hydrochloride United States Pharmacopeia (USP) Reference Standard | 34552-83-5 | 200mg | $455 | 2026-04-30 | Buy |
Loperamide hydrochloride Chemical Properties,Uses,Production
Preparation
The preparation process of loperamide hydrochloride is as follows: (1) Loperamide hydrochloride, meglumine, sodium dodecyl sulfate, and 20g of lactose are mixed evenly in a V-type mixer. The mixing speed is set to 8 rpm, and the mixture is mixed for 20 minutes to obtain mixture A; (2) Mixture A, magnesium stearate, and the remaining lactose are mixed evenly in an automatic lifting mixer. The mixing speed is set to 10 rpm, and the mixture is mixed for 15 minutes. The above powder is then filled into gelatin empty capsules to obtain the final product.
Chemical Properties
White Solid
Originator
Imodium,Janssen,UK,1975
Uses
Labeled Loperamide, which is used as an antidiarrheal
Uses
Ca channel blocker
Uses
Loperamide hydrochloride is a Ca2+ channel protein inhibitor and MOR activator.
Indications
Loperamide hydrochloride (Imodium) structurally resembles both haloperidol and meperidine. In equal doses, loperamide protects against diarrhea longer than does diphenoxylate. It reduces the daily fecal volume and decreases intestinal fluid and electrolyte loss. Loperamide produces rapid and sustained inhibition of the peristaltic reflex through depression of longitudinal and circular muscle activity.The drug also possesses antisecretory activity, presumably through an effect on intestinal opioid receptors.
Definition
ChEBI: A hydrochloride obtained by combining loperamide with one equivalent of hydrochloric acid. Used for treatment of diarrhoea resulting from gastroenteritis or inflammatory bowel disease.
Manufacturing Process
23.6 parts of 2-oxo-3,3-diphenyl-tetrahydrofuranare melted at 100°C in an
oil-bath and gaseous hydrogen bromide is introduced into it during 3 hours.
The reaction mixture is cooled and triturated in benzene. The product is
filtered off, washed with petroleum ether and dried in an exsiccator, yielding
4-bromo-2,2-diphenylbutyric acid; MP 127.5%.
To a stirred suspension of 16 parts of 4-bromo-2,2-diphenylbutyric acid in 150
parts of chloroform are added dropwise 16 parts of thionyl chloride and the
whole is stirred and refluxed for 2 hours. The reaction mixture is evaporated,yielding 4-bromo-2,2-diphenyl-butyrylchloride as a residue.
60 parts of 4-bromo-2,2-diphenylbutyrylchloride are dissolved in 400 parts of
toluene and gaseous dimethylamine is introduced slowly into the solution
while cooling (temperature is kept at about 0°C). The introduction is ceased
when dimethylamine escapes from the cooler, and stirring is continued for 2
hours at ordinary temperature. The precipitated product is filtered off and
dissolved in a minimum quantity of water. The product is extracted with
chloroform. The extract is dried and evaporated. The residue solidifies on
triturating in 4-methyl-2-pentanone. The solid is filtered off and dried, yielding
dimethyl -(tetrahydro-3,3-diphenyl-2-furylidene)ammonium bromide; MP 169°
to 171.5°C.
A mixture of 6.33 parts of 4-(p-chlorophenyl)-4-piperidinol, 8 parts of sodium
carbonate, 0.2 part of potassium iodide and 240 parts of 4-methyl-2-
pentanone is distilled azeotropically. Then there are added 12.12 parts of
dimethyl-(tetrahydro-3,3-diphenyl-2-furylidene)ammonium bromide (from the
preceding step) and the whole is stirred and refluxed for about 15 hours. The
reaction mixture is filtered hot and the filtrate is evaporated.
The oily residue is dissolved in 2-propanol and to this solution is added an
excess of 2-propanol previously saturated with gaseous hydrogen chloride.
The whole is evaporated and the oily residue is warmed in diluted hydrochloric
acid solution. Upon the addition of toluene, the salt is precipitated. It is
filtered off, boiled in acetone, and filtered off again after cooling, yielding 4-
(p-chlorophenyl)-4-hydroxy-N,N-dimethyl-α,α-diphenylpiperidine-1-butyramide
hydrochloride; MP 222.1°C.
brand name
Imodium (Janssen); Imodium (McNeil).
Therapeutic Function
Antidiarrheal
General Description
Loperamide is an antidiarrheal agent used in controlling acute nonspecific diarrhea and chronic diarrhea associated with inflammatory bowel diseases.
Biological Activity
High affinity μ -opioid receptor agonist with peripheral selectivity (K i values are 2, 48 and 1156 nM for μ -, δ - and κ -opioid receptors respectively). Antidiarrhoeal and antihyperalgesic agent. Also a Ca 2+ channel blocker; at low micromolar concentrations it blocks broad spectrum neuronal HVA Ca 2+ channels and at higher concentrations it reduces Ca 2+ flux through NMDA receptor operated channels.
Biochem/physiol Actions
Loperamide hydrochloride (HCl) is a non-selective Ca2+ channel blocker. At nanomolar concentrations, it binds to μ-opioid receptors. Loperamide HCl does not cross the blood-brain barrier.
Mechanism of action
Loperamide also is a potent inhibitor of intestinal CYP3A4, increasing the intestinal absorption of other CYP3A4 substrates. The clinically significant drug interactions of loperamide with coadministered CYP3A4 and CYP2C8 substrates or inhibitors would be limited, however, because of its two metabolic pathways.
Pharmacokinetics
Loperamide is marketed as capsules (2 mg) and liquid (1 mg/5 mL) preparations. The recommended dose is 4 mg initially and an additional 2 mg following each diarrheal stool. The dose should not exceed 16 mg/day. It is too lipophilic to dissolve in water for an intravenous dosage form, a property that limits its abuse potential. The compound is highly lipophilic and undergoes slow dissolution, thus limiting the bioavailability of the agent to approximately 40% of the dose. Its low oral bioavailability also can be attributed to first-pass metabolism by both CYP2C8 and CYP3A4 to its primary N-demethyl metabolite. Peak plasma levels are reached in approximately 5 hours, with an elimination half-life of approximately 11 hours. Approximately 1% of the dose is excreted into the urine unchanged.
Clinical Use
Loperamide is effective against a wide range of secretory stimuli and can be used in the control and symptomatic relief of acute diarrhea that is not secondary to bacterial infection.
Side effects
Adverse effects associated with its use include abdominal pain and distention, constipation, dry mouth, hypersensitivity, and nausea and vomiting.
storage
Room temperature
Loperamide hydrochloride Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Wuhan Yuqing Jiaheng Pharmaceutical Co., Ltd | 027-83850128 18207128853 | 3860188266@qq.com | China | 992 | 58 |
| Shandong Yihong Chemical Co. LTD | 15253143303 15269100373 | 977495915@qq.com | China | 490 | 58 |
| Shanghai Gukang Biotechnology Co., LTD | 13564510648 | 2985380065@qq.com | China | 111 | 58 |
| xi'an renyang Biotechnology Co., Ltd. | 13299086402 | renyangbiotech@163.com | China | 93 | 58 |
| Guangzhou Jicheng Import and Export Trading Co.，Ltd | 13682223272 | 173901442@qq.com | China | 477 | 58 |
| Wuhan Juchengyuan Biotechnology Co., Ltd | 400-027-6007 18062142210 | 804180422@qq.com | China | 145 | 58 |
| J & K SCIENTIFIC LTD. | 18210857532 18210857532 | jkinfo@jkchemical.com | China | 96815 | 76 |
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 18930552037 | 3bsc@sina.com | China | 15813 | 69 |
| TCI (Shanghai) Development Co., Ltd. | 021-67121386 | Sales-CN@TCIchemicals.com | China | 24512 | 81 |
| Energy Chemical | 400-0056266 | sales8178@energy-chemical.com | China | 44850 | 61 |
Related articles
- Loperamide Hydrochloride: Therapeutic Antidiarrheal Use and Abuse Risks
- Loperamide hydrochloride is an over-the-counter antidiarrheal , while high-dose abuse causes CNS issues and severe cardiotoxic....
- Oct 27,2025
View Lastest Price from Loperamide hydrochloride manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-09-12 | Loperamide hydrochloride
34552-83-5
|
0.99 | RongNa Biotechnology Co.,Ltd | ||||
 |
2026-09-11 | Loperamide hydrochloride
34552-83-5
|
$75.00-100.00 | 1kg | 99% | 5000Ton | HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD | |
 |
2026-09-01 | Loperamide HCl ; Loperamide Hydrochloride
34552-83-5
|
1kg | 99% | 10000kg | Shaanxi TNJONE Pharmaceutical Co., Ltd |
-
- Loperamide hydrochloride
34552-83-5
- 0.99
- RongNa Biotechnology Co.,Ltd
-
- Loperamide hydrochloride
34552-83-5
- $75.00-100.00
- 99%
- HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
-
- Loperamide HCl ; Loperamide Hydrochloride
34552-83-5
- $0.00
- 99%
- Shaanxi TNJONE Pharmaceutical Co., Ltd
